| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3801074 | Medicina Clínica | 2009 | 5 Pages |
Abstract
The observed response rates and tolerability profile are similar to those reported previously. Anagrelide is well tolerated and effective in reducing platelets to target levels in patients with ET.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Manuel Giralt, Victor Navas, Luis Hernández-Nieto, Carmen Burgaleta, F. Carbonell, Gemma RamÃrez, Vicente Vicente, Carlos Besses,